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Abstract
Background: Mesenchymal stem cells (MSCs) are multipotent cells with the potential to
differentiate into bone, cartilage, fat and muscle cells and are being investigated for their utility in
cell-based transplantation therapy. Yet, adequate methods to track transplanted MSCs in vivo are
limited, precluding functional studies. Quantum Dots (QDs) offer an alternative to organic dyes and
fluorescent proteins to label and track cells in vitro and in vivo. These nanoparticles are resistant to
chemical and metabolic degradation, demonstrating long term photostability. Here, we investigate
the cytotoxic effects of in vitro QD labeling on MSC proliferation and differentiation and use as a
cell label in a cardiomyocyte co-culture.
Results: A dose-response to QDs in rat bone marrow MSCs was assessed in Control (no-QDs),
Low concentration (LC, 5 nmol/L) and High concentration (HC, 20 nmol/L) groups. QD yield and
retention, MSC survival, proinflammatory cytokines, proliferation and DNA damage were
evaluated in MSCs, 24 -120 hrs post QD labeling. In addition, functional integration of QD labeled
MSCs in an in vitro cardiomyocyte co-culture was assessed. A dose-dependent effect was measured
with increased yield in HC vs. LC labeled MSCs (93 ± 3% vs. 50% ± 15%, p < 0.05), with a larger
number of QD aggregates per cell in HC vs. LC MSCs at each time point (p < 0.05). At 24 hrs >90%
of QD labeled cells were viable in all groups, however, at 120 hrs increased apoptosis was
measured in HC vs. Control MSCs (7.2% ± 2.7% vs. 0.5% ± 0.4%, p < 0.05). MCP-1 and IL-6 levels
doubled in HC MSCs when measured 24 hrs after QD labeling. No change in MSC proliferation or
DNA damage was observed in QD labeled MSCs at 24, 72 and 120 hrs post labeling. Finally, in a
cardiomyocyte co-culture QD labeled MSCs were easy to locate and formed functional cell-to-cell
couplings, assessed by dye diffusion.
Conclusion: Fluorescent QDs label MSC effectively in an in vitro co-culture model. QDs are easy
to use, show a high yield and survival rate with minimal cytotoxic effects. Dose-dependent effects
suggest limiting MSC QD exposure.
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Cell transplantation therapy using adult derived bone
marrow mesenchymal stem cells (MSCs) is currently
being investigated as a potential therapy to treat injured
heart tissue [1,2]. Transplanted MSCs are expected to
engraft, differentiate and remodel in response to the sur-
rounding cardiac microenvironment resulting in tissue
regeneration and functional repair. The mechanisms
underlying MSC engraftment and electrical and mechani-
cal integration with host cardiac tissue are not under-
stood. In part, this is due to limited methods to track
MSCs in vivo, precluding long-term functional studies of
transplanted cells. Current methods for labeling MSCs
include ultra small iron particles (superparamagnetic iron
oxide) [3], radioactive labels ([111In] indium oxine) [4],
and organic fluorescent dyes loaded exogenously into
cells [5] or fluorescent proteins expressed by the cells [6].
Yet, chemical and metabolic degradation, reduced photo-
stability and signal quality [7] compromise in vitro and in
vivo cell labeling and tracking.
Nanotechnology is focused on the development of nano-
scale materials and devices with use in biomedicine for
drug delivery, diagnostics, imaging and cell tracking.
Quantum dots (QDs) are fluorescent semiconductor nan-
oparticles, recently adopted for use in in vitro and in vivo
bioimaging [8,9]. Reported advantages of QDs include a
narrow band emission and broadband excitation with a
high quantum yield, photostability, luminescence and
resistance to chemical and metabolic degradation
[8,10,11]. These properties make QDs amenable to multi-
color imaging applications and the tracking of live cells
[12]. Reports in the literature suggest that QDs are non-
cytotoxic [8,13], while recent data suggests QD cytotoxic-
ity due to different physicochemical properties, dose and
exposure concentrations [14-18]. Most QD applications
have utilized non-mammalian or cancer cells with only a
few studies examining deleterious effects of QDs in MSCs
[8,18-20].
In the present study, rat bone marrow MSCs were used to
evaluate QD exposure on labeled MSC yield, QD reten-
tion and proliferation. In addition, proinflammatory
cytokines and DNA damage were examined to measure
cellular responses to QD stimuli in vitro. We assessed the
ability to track QD labeled MSCs in an in vitro cardiomy-
ocyte co-culture. Finally, using a dye transfer assay func-
tional cell-to-cell coupling of the MSCs with
cardiomyocytes was assessed. Our results show bright,
photostable QD labeled MSCs coupled functionally with
cardiomyocytes in co-culture, indicating that QDs show
promise as a cell labeling agent for studies tracking the
fate of MSCs in culture. Dose-dependent cytotoxic effects
suggest that QD exposure be limited to low concentra-
tions for long-term in vivo cell transplantation studies.
Results
QD yield and intracellular distribution
Flow cytometry and confocal microscopy assessed intrac-
ellular QD labeling at 24, 72 and 120 hrs in Control
(media only), High QD concentration (HC, 20 nmol/L)
and Low QD concentration (LC, 5 nmol/L) MSC groups.
Flow cytometry results, shown in Figure 1a, illustrate a
dose-dependent effect with increased HC vs. LC QD
labeled MSCs (93% ± 3% vs. 50% ± 15%, p < 0.05) meas-
ured 24 hrs post QD labeling. As the MSCs proliferated in
culture the number of QD labeled MSCs detected with
flow cytometry decreased to 64% ± 12% vs. 25% ± 9% at
72 hrs and 48% ± 10% vs. 19% ± 10% at 120 hrs in the
HC vs. LC MSCs (p < 0.05). Confocal images were used to
quantitate intracellular QD aggregates. For each group
(HC and LC) and at each time point (24, 72, 120 hr) an
average of 100 cells were evaluated. The average number
of QD aggregates in the HC MSCs was greater than in the
LC MSCs at each time point (p < 0.05), shown in Figure
1b. Similar to findings by Seleverstov et. al. [18] and
Rosen et. al. [20] QDs tended to form large intracellular
aggregates in the MSCs. This observation resulted in the
average number of QD aggregates recorded in MSCs
increasing from 24 to 72 hrs in both groups of MSCs (p <
0.05). No statistically significant differences in intracellu-
lar QD aggregate numbers were observed from 72 to120
hrs. Figure 1c illustrates QD location and distribution in
live MSCs at 24 and 120 hrs post labeling. For both expo-
sure groups QDs were detected with confocal fluorescence
microscopy and distributed in the cytosol with no QDs
detected in the nucleus. TEM images of MSCs labeled with
QDs are shown in Figure 2. QD aggregates were found in
the MSC vesicles (panel a) around the nucleus (similar to
the confocal images) in agreement with Seleverstov et. al.
[18]. At high resolution (panel b, 105 × magnification)
individual QDs were observed in the vesicles with an aver-
age diameter of 9.8 ± 1.0 nm.
MSC survival
To determine whether QDs induced apoptotic cell death,
MSCs were labeled with Annexin V and flow cytometry
analysis assessed MSC viability identifying apoptosis in
the cell population post QD labeling. Shown in Figure 3,
at 24 hrs > 90% of QD labeled MSCs were viable in LC,
HC and Control MSCs (no QD exposure). Apoptosis
increased in HC MSCs vs. Control MSCs 120 hr post QD
labeling (7.2% ± 2.7% vs. 0.5% ± 0.4%, p < 0.05).
Cytokine release
Monocyte Chemoattractant Protein-1 (MCP-1), Inter-
leukin-6 (IL-6), Interleukin-1 Beta (IL-1β) and Tumor
Necrosis Factor alpha (TNF-α) levels were measured 24
hrs post QD labeling. The levels of MCP-1 and IL-6 dou-
bled in HC MSCs compared to the LC MSCs and Control
MSCs. There was no difference in the levels of MCP-1 andPage 2 of 9
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LC) or increase above Control MSCs was measured in
cytokine levels of IL-1β and TNF-α 24 hrs post QD labe-
ling.
Cell proliferation and DNA damage
No change in MSC metabolic activity as a measure of pro-
liferation was recorded at 24, 72, and 120 hrs after QD
labeling in LC, HC and Control MSCs. DNA damage was
assessed with the micro-scale cell-based comet bioassay.
Single and double strand DNA damage was identified by
Intracellular QD yield, retention and distribution in expand-i g MSC culturesFi ur  1
Intracellular QD yield, retention and distribution in 
expanding MSC cultures. a. Flow cytometry results of 
QD positive MSCs in HC and LC groups at 24, 72 and 120 
hrs post labeling. A dose-dependent effect is shown with 
increased HC vs. LC QD labeled MSCs detected at each time 
point (p < 0.05). b. Quantitative imaging results show a 
greater number of QD aggregates in the HC vs. LC MSCs at 
each time point (p < 0.05). The average number of intracellu-
lar QD aggregates increased from 24 to 72 hrs in both 
groups of MSCs (p < 0.05). No statistically significant changes 
in QD aggregates were measured from 72 – 120 hr. c. Rep-
resentative confocal fluorescent images of LC and HC MSCs 
co-labeled with calcein (green) at 24 and 120 hrs. Each image 
represents a 1 μm thick optical slice establishing a peri-
nuclear intracellular distribution of QDs. As the MSCs prolif-
erated QDs remained bright and easy to detect. Scale bar 20 
μm.
TEM of QD labeled MSCFigure 2
TEM of QD labeled MSC. a. Low magnification, repre-
sentative image of MSC with QD nanocrystal aggregates in 
endosomal vesicles around nuclear membrane (nm, arrow-
head). Scale bar 2 μm. b. High magnification of enlarged sin-
gle vesicle (arrow, a and b) showing individual QDs. Scale bar 
500 nm.Page 3 of 9
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reported as tail moment. The results, (data not shown)
suggest a trend toward increased DNA damage with
increased QD dose. Nevertheless, there was no statistically
significant difference in comet tail moment measured in
LC and HC MSCs compared to Control MSCs.
In vitro model
Identification of QD labeled MSCs in co-culture with car-
diac myocytes was evaluated with fluorescence confocal
microscopy, imaging through the Z axis. QD labeled
MSCs were identified by punctate red fluorescent cellular
inclusions as shown in Figure 4. The QDs appear to be
localized to the MSCs. In preliminary studies, using the
manufacture's protocol for labeling tumorigenic cell lines,
we were unable to intracellularly label the cardiac myo-
cytes with QDs. Figure 5 illustrates the 3D distribution
and location of QDs in cardiac myocytes and MSCs 24 hrs
post labeling. This figure clearly shows the QD aggregates
on the surface of the cardiac myocyte, while the QDs are
more diffusely located in the MSC cytosol. Gap junction-
mediated cell-to-cell communication between the cardiac
myocytes and MSCs was evaluated in the co-culture
model using confocal microscopy and a fluorescent dye
diffusion assay (fluorescence recovery after photobleach-
Effect of QD labeling on apoptotic cell death in Control and QD labeled MSCsFigure 3
Effect of QD labeling on apoptotic cell death in Con-
trol and QD labeled MSCs. Flow cytometry results at 24, 
72 and 120 hrs after QD labeling. The percent of annexin 
positive QD labeled MSCs was similar for HC, LC and Con-
trol MSCs at 24 hrs post labeling. Increased apoptosis was 
observed in HC vs. Control MSCs at 120 hrs (*p < 0.05). No 
difference in apoptosis was detected in LC vs. Control MSCs.
QD labeled MSC in cardiac myocyte co-culture at 7 daysFigure 4
QD labeled MSC in cardiac myocyte co-culture at 7 
days. Images show optical sections acquired as a confocal Z 
stack with 1-μm spacing. Image a shows QD labeled MSC 
above cardiac myocytes. As images advance into the cell cul-
ture (a – e, towards coverslip) the QD labeled MSC is shown 
adjacent to and surrounded by cardiac myocytes. All cells 
were labeled with the cytosolic fluoroprobe calcein AM. 
QDs are preferentially localized in the MSC. No QDs were 
found to be localized in the cardiac myocytes. All images 
were acquired with an oil immersion 40× objective. Scale bar 
20 μm.Page 4 of 9
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shown in Figure 6a–c, illustrating the FRAP protocol and
fluorescence recovery in the MSC. The graph in Figure 6d
shows the average fluorescence recovery over 5 minutes
measured in QD labeled MSCs adjacent to cardiac myo-
cytes (n = 6). Fluorescence recovery time is comparable to
published results from similar stem cell-myocyte co-cul-
ture models [21].
Discussion
Stem cell transplantation is currently being investigated as
a potential therapy for chronic heart failure. While this
novel, innovative approach for treating injured or dam-
aged heart muscle has reported positive results with
MSCs, the mechanisms underlying functional improve-
ment are not known. This research was initiated as in vitro
and in vivo studies necessary to elucidate stem cell engraft-
ment and function have been limited due to current stem
cell labeling and tracking techniques.
Commercially available CdSe/ZnS QDs were used at con-
centrations of 5 nmol/L (LC) and 20 nmol/L (HC) to eval-
uate the cytotoxic effects on rat mesenchymal stem cells
(MSCs). The two concentrations were selected as they rep-
resented one-half and twice the manufacturer recom-
mended QD labeling dose. Adhering to the
manufacturer's instructions for QD labeling time of 1 hr
we found that QD exposure resulted in a high yield of via-
ble, labeled MSCs that were bright, photo-stable and visi-
ble in live cell cultures for up to 7 days. Preliminary
studies in our laboratory suggest that alternative cell track-
ing probes for longer term cell tracking, i.e. 24 hrs, are less
photostable with low fluorescence emission intensities
when evaluated in 7 day live cell cultures (data not
shown). Cytotoxic effects were minimal; QD exposure did
not interfere with metabolic activity or significantly affect
DNA structure. However, at the higher QD concentration
we did find a dose-dependent increase in apoptotic cell
death and increase in cytokine release. Similar to recent
findings by others [18,20], confocal microscopy and TEM
showed that QD aggregates localized in endosomal vesi-
cles in the peri-nuclear region of the MSCs.
At both the low and high concentrations QDs appear to
be cytocompatible with the MSCs and capable of labeling
proliferating stem cells in vitro. These results suggest that
when using QDs to label and track stem cells, QD concen-
tration and exposure time should be optimized to reduce
cytotoxic effects. The Qtracker cell labeling kit combined
QDs with a custom targeting peptide to improve QD sol-
ubility and intracellular delivery. With this delivery sys-
tem QDs had the tendency to aggregate and intracellular
QD aggregates were more abundant and appeared larger
at higher QD concentrations. This increase in intracellular
QD aggregate size and number may have contributed to
3D distribution and localization of QDs in MSCs and cardiac myocy esFigure 5
3D distribution and localization of QDs in MSCs and 
cardiac myocytes. A cut view through 12 (a) and16 (b) 
superimposed optical sections illustrating the 3D distribution 
of QDs in MSC and Cardiac Myocyte cultures 24 hrs post 
QD labeling. The sections shown are taken from the intracel-
lular space of the cells indicated by the blue arrows with the 
red (vertical) and green (horizontal) crosshairs aligned near 
QD aggregates. a. The QDs are homogeneously distributed 
through the MSC cytosol, have not formed large aggregates 
and are clearly visualized in the intracellular space as indi-
cated by the red arrow. Scale bar = 20 μm. b. 3D distribution 
of QDs in the cardiomyocyte culture clearly show QDs 
located on the cell surface as indicated by the red arrow. No 
QD uptake was observed in the cytosol of the cardiac myo-
cyte. Scale bar = 20 μm.Page 5 of 9
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centrations and longer exposure times may yield smaller
QD aggregates and reduced cytotoxic effects with similar
QD labeling yield. The development of cell-penetrating
QDs may require lower QD labeling concentrations [22],
while factors such as surface charge, core size and incuba-
tion media have been identified as important for uniform
and complete labeling [18,20]. In addition, reports sug-
gest that QDs are sensitive to environmental factors such
as pH, salts, oxidation and temperature [23,24]. These fac-
tors were not evaluated but should be considered when
used with MSCs for in vitro and in vivo applications.
Our results suggest that labeled MSCs should be used
within the first 24 hrs after QD labeling when evaluated in
a co-culture system, as detection of QD labeled MSCs
decreased as cells proliferated in culture. Documentation
by the manufacturer stated that QDs are inherited by
daughter cells for at least 6 generations. It is possible that
flow cytometry was not sensitive enough to detect intrac-
ellular QDs in MSCs as they proliferated over time. It is
hypothesized that asymmetric cell division and unequal
division of endosomes to daughter cells could result in a
dilution of QD labeling as MSCs proliferate [18]. Our
results support this as confocal image analysis showed
that the number of QD aggregates did not change substan-
tially 72 hrs after labeling and fewer QD labeled MSCs
were detected. Yet, it is important to note that for in vitro
and in vivo cell tracking studies, QD labeled MSCs are
expected to be transplanted within 24 hrs of QD labeling
and to engraft and differentiate in the host environment,
maintaining their cellular label.
Results of this study address only QD effects on proliferat-
ing MSCs, cell tracking and engraftment in in vitro co-cul-
tures. While QDs appear to be safe to use in MSCs, it is
believed that a low percentage of transplanted MSCs
engraft during cellular cardiomyoplasty. Presently, the
mechanism of metabolism or clearance of QDs from
transplanted cells in vivo is not understood. In vitro studies
in our laboratory suggest that when compared to MSCs
and under similar labeling conditions, cardiac myocytes
do not readily endocytose QDs. However, animal studies
show that QDs accumulate in bone marrow, spleen and
liver for up to 4 months [25]. The outer shell of the QD is
inert, while the inner cadmium core is toxic. While it is
unlikely that chemical or enzymatic degradation of the
outer shell occurs in organs that accumulate QDs, this
information is not available. In addition, while increased
cytokine release was not significant for LC MSCs both
MCP-1 and IL-6 were elevated after HC QD labeling.
While increased cytokines did not affect MSC prolifera-
tion, this finding may be relevant in applications where
QD labeled MSCs are transplanted into injured or dis-
eased tissue where cytokine levels are elevated, contribut-
Functional gap junction mediated MSC- cardiac myocyte commu ication i  QD lab led MSCigure 6
Functional gap junction mediated MSC- cardiac myo-
cyte communication in QD labeled MSC. Fluorescence 
recovery in calcein labeled co-culture with QD labeled MSC 
(noted by dashed white border and arrow) adjacent to myo-
cytes, a. before photobleach b. immediately after photob-
leach and c. 5 min. after photobleach. d. Corresponding 
graph illustrating average fluorescence recovery time (n = 6). 
Scale bar = 20 μm.Page 6 of 9
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vivo animal testing is necessary to evaluate QD labeled
MSC engraftment and efficacy in damaged heart muscle.
Conclusion
Results of this study provide new information concerning
the cytocompatibility of QDs on MSCs and their use as a
label to track MSCs to evaluate MSC function in an in vitro
cardiac myocyte co-culture. To the author's knowledge,
this is the first report showing functional integration of
QD labeled MSCs in a cardiac microenvironment. Quan-
tum dot labeled MSCs were bright, photostable and easy
to track in live co-cultures providing the opportunity for
functional studies in heterogeneous cell cultures. Dose-
dependent cytotoxic effects suggest that initial QD expo-
sure be optimized and limited to low concentrations.
Future applications of QDs, in addition to long term in
vivo cell tracking and imaging, may involve combination
with drug delivery systems to treat and monitor injured
heart tissue.
Methods
Cell cultures
MSCs were isolated from 6 week old male Fisher rats using
Caplan's method [26] in accordance with the accepted
guidelines of the care and treatment of experimental ani-
mals at East Carolina University and the National Insti-
tutes of Health. Under sterile conditions the femur and
tibia were flushed with Dulbecco's Minimal Essential
Medium (DMEM, Gibco, Grand Island, NY) supple-
mented with 10% Fetal Bovine Serum (FBS, Hyclone,
Logan, UT) and 1% penicillin, streptomycin and incu-
bated at 37°C, 5% CO2. Non-adherent cells were removed
at 24 hrs and every 2 days there after for 1 week. Adherent
cells were trypsinized, replated for expansion and grown
to 80% confluence.
Quantum dot labeling
MSCs were labeled with Q-Tracker 605 Cell Labeling kit
(Invitrogen, Carlsbad, CA). These QDs, approximately
10–15 nm in diameter, are composed of a cadmium sele-
nium core and an inner zinc sulfide shell (CdSe/ZnS). A
custom peptide bonded to the QD's outer shell allows the
QD to be endocytosed into the cell interior and exist in
periplasmic vesicles [9,27]. Growth medium containing 0
nmol/L(Control), 5 nmol/liter (LC) or 20 nmol/L (HC)
QDs was added to 1 × 106 MSCs in suspension and incu-
bated for 1 hr at 37°C, 5% CO2 according to the instruc-
tions of the manufacturer. The QD concentrations
evaluated were one-half (LC) and twice (HC) the manu-
facturer's recommended labeling concentrations. MSCs
were washed, resuspended in full growth media, plated
and allowed to expand for 24, 72, and 120 hrs. Observa-
tions of live cells were terminated at 120 hrs.
MSC survival and QD yield
To assess QD yield, retention and MSC viability an
Annexin-V-Fluos staining kit (Roche, Mannheim, Ger-
many) and flow cytometry were used at 24, 72 and 120
hrs post QD labeling (n= 3 cell isolations). Flow cytome-
try identified MSC populations as QD positive or negative
and further separated the cells into annexin positive or
negative groups. The annexin assay identified MSCs
undergoing apoptosis. Briefly, MSCs exposed to media or
QDs were trypsinized, counted and washed with PBS
(Phosphate Buffered Solution). According to manufac-
turer's directions, Annexin-V-Fluos labeling solution was
added to 2 × 105 cells in the Control, LC, and HC groups
and MSCs were analyzed on a Becton Dickinson FACScan
flow cytometer with CellQuest software (BD Biosciences,
San Jose, CA).
Intracellular distribution of QDs
Confocal fluorescence images were acquired with a Zeiss
LSM 510 inverted microscope (Zeiss LSM 510, Carl Zeiss,
Oberkochen, Germany) equipped with a with a 63X/1.4
NA water immersion objective. Control, LC and HC MSCs
were plated on coverslips coated with poly-L-lysine in full
growth media and incubated at 37°C, 5% CO2. After 24,
72 and 120 hrs the media was removed and cells were
rinsed with PBS. Images of QD intracellular distribution
in live MSCs at 24 and 120 hrs were acquired for each
MSC isolation (n = 3). To observe MSCs under fluores-
cence microscopy, the MSCs were labeled with 1 μmol/L
calcein acetoxymethylester (calcein AM; Invitrogen,
Eugene, OR) and imaged with a 488 nm argon excitation
laser excitation and 515 ± 15 nm band pass filter. Quan-
tum dots were imaged with a 458 nm argon excitation
laser and 580 nm long-pass filter. For each time point and
QD concentration, an average of 100 cells were imaged
and evaluated to quantify QD aggregates. ImageJ software
http://rsb.info.nih.gov/ij was used to evaluate QD loca-
tion, aggregate number and distribution in MSCs.
Transmission electron microscopy (TEM) was performed
to further determine QD location in the MSCs. Twenty
four hrs post QD labeling, MSCs were trypsinized, pel-
leted, washed with PBS, and fixed with 2%glutaraldehyde.
Pelleted cells were washed in Na Cacodylate buffer,
treated with 1% Osmium tetroxide, rinsed with PBS and
dehydrated in graded ethanol. The cell pellet was treated
with acetone, and embedded in Spurr's resin. Thin sec-
tions (80 nM) were cut and mounted on copper grids.
Images were collected at 15,000× to 250,000× on a
60,000 Kv Jeol 1200EX (Jeol Ltd, Waterford, VA) and ana-
lyzed with iTEM (Soft Imaging System, Lakewood, CO).
DNA damage
To assess single and double strand DNA damage a single
cell gel electrophoresis assay was used at 72 and 120 hrsPage 7 of 9
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burg, MD). Per manufacturer's instructions, MSCs
exposed to media or QDs were harvested and 100,000
cells per group were pelleted and resuspended in ice cold
PBS. As a positive control, a group of Control MSCs were
treated with 100 μmol/L hydrogen peroxide (H2O2, a
known DNA oxidizer) for 10 minutes at 4°C, and then
washed with PBS. MSCs were plated on pre-treated comet
slides, placed in lysis solution for 1 hr at 4°C and in alka-
line solution for 40 minutes at 21°C. Electrophoresis was
performed at 4°C with 30 V for 45 minutes. Cells were
dehydrated in 70% ethanol. Total DNA was stained with
SYBR Green.
Comet assay slides were imaged with a Zeiss LSM 510 flu-
orescence microscope equipped with a 20X/0.50 NA
objective and 505 nm long-pass filter. The comet tail
moment was analyzed with comet scoring software
(Northern Eclipse, North Tonawanda, NY). The tail
moment was calculated as the product of the tail length
and the fraction of signal in the comet tail [28]. Double
and single strand DNA damage was identified by
increased dispersion patterns of the comet tail. Three rep-
licate experiments were performed.
Cytokine release
The inflammatory response of the MSCs to the QDs was
evaluated with a rat cytokine/chemokine Lincoplex kit
(Linco Research Inc, St.Charles, MO) and Luminex 100
analyzer (Luminex Corp, Austin, TX). Media from MSCs
24 hrs post QD labeling was removed and spun at 1500
rpm for 5 minutes. The supernatant was removed and
assayed for MCP-1, IL-6, IL-1β and TNF-α.
Cell proliferation
Metabolic activity of MSCs at 24, 72 and 120 hrs was
measured with a cell proliferation assay (CellTiter 96
Aqueous One Solution, Promega Corporation, Madison,
WI). Control and QD exposed MSCs were added in tripli-
cate to a 96 well plate. Plates were incubated for 24, 72,
and 120 hrs at 37°C, 5% CO2. At each time point, Aque-
ous One Solution was added to each well according to
manufacturer's instructions, and absorbance was read at
490 nm on a Perkin Elmer plate reader (Perkin Elmer, Inc,
Wellesley, MA). Absorbance was directly proportional to
metabolic activity. Three replicates of each treatment were
completed.
In vitro model
Rat ventricular cells were isolated and co-cultured as pre-
viously described [29]. Briefly, neonatal cardiac myocytes
were isolated from the hearts of 1 day-old Sprague-Daw-
ley rats in accordance with accepted guidelines for the care
and treatment of experimental animals at the East Caro-
lina University Brody School of Medicine and the
National Institutes of Health. Neonatal cardiac myocytes
were isolated using a Worthington Neonatal Cardiomyo-
cyte Isolation System (Worthington Biochemical Corp.,
Lakewood, NJ). The cells were plated on laminin-coated
cover slides at 1 × 106 cells per 22-mm cover slide and
grown in Richter (Irvine Scientific, Santa Ana, CA)
medium supplemented with 10% fetal calf serum. The cell
cultures were maintained for 48 hrs before the QD labeled
MSCs were added at a ratio of 1/100 and maintained in
co-culture up to 7 days.
A fluorescent dye diffusion assay, fluorescence recovery
after photobleaching (FRAP) was used with confocal
microscopy to evaluate functional cell-to-cell communi-
cation via gap junctions in the cardiac cell cultures as pre-
viously described [21,29]. The cells in co-culture were
intracellularly labeled with the fluoroprobe calcein AM.
MSCs were identified through intracellular QD fluores-
cence (previously described). Using a high intensity set-
ting for the 488 nm argon laser on the Zeiss LSM 510
microscope, calcein was bleached in MSCs adjacent to
neonatal cardiomyocytes. The MSCs demonstrated fluo-
rescence recovery after photobleaching as a result of cal-
cein diffusion from neighboring cardiomyocytes into the
MSCs. Functional cell coupling was assessed at room tem-
perature (21°C).
Statistical analysis
The data are presented as mean ± SEM. The statistical sig-
nificance was determined using a Student's T-test and
analysis of variance (ANOVA) where appropriate. A p
value less than 0.05 was considered statistically signifi-
cant.
Abbreviations
HC - High Concentration 
IL-1β - Interleukin-1 
IL-6 - Interleukin-6
LC - Low Concentration
MCP-1 - Monocyte Chemoattractant Protein-1
MSC - Mesenchymal stem cell
QD - quantum dot 
TNF-α - Tumor Necrosis Factor alpha.
Competing interests
The author(s) declare that they have no competing inter-
ests.Page 8 of 9
(page number not for citation purposes)
Journal of Nanobiotechnology 2007, 5:9 http://www.jnanobiotechnology.com/content/5/1/9Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Authors' contributions
BJMB and WEC initiated these studies. BJMB and APK
supervised experimental design, reviewed data and pro-
vided statistical support. MCC and PRG carried out the
experiments, data analysis and statistics. BJMB drafted
and finalized the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
The authors would like to acknowledge Randall Renegar, PhD, Professor of 
Anatomy, ECU Brody School of Medicine for his assistance in preparing and 
acquiring the TEM data. This work was supported by the Murray and Sydell 
Rosenberg Foundation, NY.
References
1. Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C,
Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher
AM: Transplantation of progenitor cells and regeneration
enhancement in acute myocardial infarction final one-year
results of the TOPCARE-AMI trial.  Journal of the American Col-
lege of Cardiology 2004, 44(8):1690-1699.
2. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Brei-
denbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L,
Hertenstein B, Ganser A, Drexler H: Intracoronary autologous
bone-marrow cell transfer after myocardial infarction: the
BOOST randomized controlled clinical trial.  Lancet 2004,
364:141-148.
3. Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C,
Dubus I, Ivanovic Z, Jean Rosenbaum J, Charbord P, Combe C, Bulte
JWM, Moonen CTW, Ripoche J, Grenier N: In vivo MR imaging of
intravascularly injected magnetically labeled mesenchymal
stem cells in rat kidney and liver.  Radiology 2004, 233:781-789.
4. Stodilka RZ, Blackwood KJ, Prato FS: Tracking transplanted cells
using dual-radionuclide SPECT.  Physics in Medicine and Biology
2006, 51:2619-2632.
5. Templin C, Kotlarz D, Marquart F, Faulhaber J, Brendecke V, Schaefer
A, Tsikas D, Bonda T, Hilfiker-Kleiner D, Ohl L, Naim HY, Foerster
R, Drexler H, Limbourg FP: Transcoronary delivery of bone
marrow cells to the infarcted murine myocardium: feasibil-
ity, cellular kinetics, and improvement in cardiac function.
Basic Research in Cardiology 2006, 101:310-310.
6. Rubart M, Soonpaa MH, Nakajima H, Field L: Spontaneous and
evoked intracellular calcium transients in donor-derived
myocytes following intracardiac myoblast transplantation.
The Journal of Clinical Investigation 2004, 114:775-783.
7. Shah B, Clark P, Stroscio M, Mao J: Labeling and imaging of
human mesenchymal stem cells with quantum dot bioconju-
gates during proliferation and osteogenic differentiation in
long term.   2006, Proceedings of the 28th IEEE EMBS Annual
International Conference:1470-1473.
8. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM: Long-term multiple
color imaging of live cells using quantum dot bioconjugates.
Nature Biotechnology 2003, 21:47-51.
9. Larson DR, Zipfel WR, Williams RM, Clark S, Bruchez M, Wise F,
Webb W: Water-Soluble quantum dots for multiphoton fluo-
rescence imaging in vivo.  Science 2004, 300:1434-1436.
10. Chan W, Maxwell D, Gao X, Bailey R, Han M: Luminescent quan-
tum dots for multiplexed biological detection and imaging.
Current Opinion in Biotechnology 2002, 13:40-46.
11. Alvisiatos A: The use of nanocrystals in biological detection.
Nature Biotechnology 2004, 22:47-52.
12. Zheng J, Ghazani AA, Song Q, Mardvani S, Chan WC, Wang C: Cel-
lular imaging and surface marker labeling of hematopoietic
cells using quantum dot bioconjugates.  Laboratory Hematology
2006, 12:94-98.
13. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH,
Libchaber A: In vivo imaging of quantum dots encapsulated in
phospholipid micelles.  Science 2002, 298:1759-1762.
14. Braydich-Stolle L, Hussain S, Schlager J, Hofmann M: In vitro cyto-
toxicity of nanoparticles in mammalian germline stem cells.
  Toxicological Sciences 2005, 88:412-419.
15. Hardman R: A toxicologic review of quantum dots: toxicity
depends on physicochemical and environmental factors.
Environmental Health Perspective 2006, 114:165-172.
16. Hsieh SC, Wang FF, Hung SC, Chen YJ, Wang YJ: The internalized
CdSe/ZnS quantum dots impair the chondrogenesis of bone
marrow mesenchymal stem cells.  Journal of Biomedical Materials
Research 2006, 79B:95-101.
17. Lovric J, Cho S, Winnik F, Maysinger D: Unmodified cadmium tel-
luride quantum dots induce reactive oxygen species forma-
tion leading to multiple organelle damage and cell death.
Chemistry and Biology 2005:1227-1234.
18. Seleverstov O, Zabirnyk O, Zscharnack M, Bulavina L, Nowicki M,
Heinrich JM, Yeshelyev M, Emmirich F, O'Regan R, Bader A: Quan-
tum Dots for Human Mesenchymal Stem Cells Labeling. A
Size-Dependent Autophagy Activation.  Nano Letters 2006,
6(12):2826-2832.
19. Hsieh S, Wang F, Lin C, Chen Y, Hung S, Wang Y: The inhibition of
osteogenesis with human bone marrow mesenchymal stem
cells by CdSe/ZnS quantum dot labels.  Biomaterials 2006,
27:1656-1664.
20. Rosen AB, Kelly DJ, Schuldt AJT, Potapova IA, Doronin KJ, Robichaud
RBR, Rosen MR, Brink PR, Gaudette GR, Cohen IS: Finding fluores-
cent needles in the cardiac haystack: Tracking human mes-
enchymal stem cells labeled with quantum dots for
quantitative in vivo 3-D fluorescence analysis.  Stem Cells
Express 2007.
21. Muller-Borer BJ, Cascio WE, Esch GL, Kim HS, Coleman WB, Gri-
sham JW, Anderson PAW, Malouf NN: Mechanisms controlling
the acquisition of a cardiac phenotype by liver stem cells.  Pro-
ceedings of the National Academy of Science USA 2007,
104(10):3877-3882.
22. Duan H, Nie S: Cell-Penetrating Quantum Dots Based on Mul-
tivalent and Endosome-Disrupting Surface Coatings.  Journal
of the American Chemical Society 2007, 129:3333-3338.
23. Mattoussi H, Mauro JM, Goldman ER, Anderson GP, Sundar VC,
Mikulec FV, Bawendi MG: Self-Assembly of CdSe-ZnS quantum
dot bioconjugates using an engineered recombinant protein.
Journal of the American Chemical Society 2000, 122:12141-12150.
24. Chen YF, Rosenzweig Z: Luminescent CdS quantum dots as
selective ion probes.  Annals of Chemistry 2002, 74:5132-5238.
25. Ballou B, Langerholm BC, Ernst LA, Bruchez MP, Waggoner AS: Non-
invasive imaging of quantum dots in mice.  Bioconjugate Chemis-
try 2004, 15:79-86.
26. Caplan AI: Mesenchymal Stem Cells.  Journal of Orthopedic
Research 1991, 9(5):641-650.
27. Jaiswal JK, Goldman ER, Mattoussi H, Simo SM: Use of quantum
dots for live cell imaging.  Nature Methods 2004, 1(1):73-78.
28. Al-Baker EA, Oshin M, Hutchison CJ, Kill IR: Analysis of UV-
induced damage and repair in young and senescent human
dermal fibroblasts using the comet assay.  Mechanism of aging
and development 2005, 126:664-672.
29. Muller-Borer BJ, Cascio WE, Anderson PAW, Snowwaert JN, Frye JR,
Desai N, Esch GL, Brackham JA, Bagnell CR, Coleman WB, Grisham
JW, Malouf NN: Adult-derived liver stem cells acquire a cardi-
omyocyte structural and functional phenotype ex vivo.  Amer-
ican Journal of Pathology 2004, 165(1):135-145.Page 9 of 9
(page number not for citation purposes)
